New tool for glaucoma implant: easier placement?

NCT ID NCT07400926

Recruiting now Disease control Sponsor: Glaukos Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a redesigned inserter for the travoprost implant, a tiny device placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will receive the implant using the updated inserter. The main goal is to see if doctors can successfully follow the instructions and deliver the implant as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: travoprost implant
What this could lead to: If successful, this could make it easier and more reliable for doctors to place the travoprost implant, helping control eye pressure in glaucoma patients.
What could go wrong: This is a small, early observational study focused on the inserter device, not on whether the implant works better than existing treatments. It may not lead to any change in patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION (OH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OCULAR HYPERTENSION (OH) OPEN-ANGLE GLAUCOMA (OAG) OPEN-ANGLE GLAUCOMA, OCULAR HYPERTENSION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Glaukos Investigative Site
RECRUITING

Kenosha, Wisconsin, 53140, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.